Total Payments
$19,174
2024 Payments
$514.50
Companies
26
Transactions
444
Payment Breakdown by Category
Other$8,900 (46.4%)
Food & Beverage$7,436 (38.8%)
Research$1,206 (6.3%)
Consulting$925.00 (4.8%)
Travel$664.90 (3.5%)
Education$42.10 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,900 | 7 | 46.4% |
| Food and Beverage | $7,436 | 424 | 38.8% |
| Unspecified | $1,206 | 7 | 6.3% |
| Consulting Fee | $925.00 | 3 | 4.8% |
| Travel and Lodging | $664.90 | 1 | 3.5% |
| Education | $42.10 | 2 | 0.2% |
Payments by Type
General
$17,968
437 transactions
Research
$1,206
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $10,066 | 64 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,663 | 152 | $0 (2022) |
| Neos Therapeutics, LP | $1,331 | 15 | $0 (2019) |
| Roche Products Limited | $1,190 | 2 | $0 (2018) |
| Hoffmann-La Roche Limited | $925.00 | 3 | $0 (2019) |
| ABBVIE INC. | $780.59 | 45 | $0 (2024) |
| Shire North American Group Inc | $639.23 | 38 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $518.36 | 21 | $0 (2024) |
| Allergan, Inc. | $241.47 | 16 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $241.15 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $514.50 | 14 | Supernus Pharmaceuticals, Inc. ($383.94) |
| 2023 | $705.11 | 41 | ABBVIE INC. ($219.98) |
| 2022 | $1,371 | 95 | Sunovion Pharmaceuticals Inc. ($391.46) |
| 2021 | $9,885 | 71 | Supernus Pharmaceuticals, Inc. ($9,231) |
| 2020 | $519.71 | 38 | Sunovion Pharmaceuticals Inc. ($272.19) |
| 2019 | $2,939 | 89 | Neos Therapeutics, LP ($1,206) |
| 2018 | $2,373 | 48 | Roche Products Limited ($1,190) |
| 2017 | $866.38 | 48 | Shire North American Group Inc ($285.03) |
All Payment Transactions
444 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $33.68 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/31/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: SCHIZOPHRENIA | ||||||
| 06/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 02/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: PSYCHIATRY | ||||||
| 02/28/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 02/21/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 01/31/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: PSYCHIATRY | ||||||
| 01/29/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $183.39 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 01/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Neuropsychiatry | ||||||
| 01/11/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $69.30 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 01/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: NEUROSCIENCE | ||||||
| 12/23/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: PSYCHOLOGY | ||||||
| 12/13/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: CNS | ||||||
| 12/01/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: PSYCHOLOGY | ||||||
| 11/30/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: CNS | ||||||
| 11/15/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: CNS | ||||||
| 11/10/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $6.69 | General |
| Category: PSYCHOLOGY | ||||||
| 11/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $2.73 | General |
| Category: PSYCHOLOGY | ||||||
| 10/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: NEUROSCIENCE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| An Open-Label, Single-Dose Pharmacokinetic Study of ADZENYS XR ODT in Male and Female Children 4 to Less Than 6 Years of Age With Attention-Deficit/Hyperactivity Disorder (ADHD) | Neos Therapeutics, LP | $1,206 | 7 |
About Dr. Michael Mcmanus, MD
Dr. Michael Mcmanus, MD is a Psychiatry healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669411179.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Mcmanus, MD has received a total of $19,174 in payments from pharmaceutical and medical device companies, with $514.50 received in 2024. These payments were reported across 444 transactions from 26 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($8,900).
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Child & Adolescent Psychiatry
- Location San Diego, CA
- Active Since 06/06/2006
- Last Updated 03/15/2021
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1669411179
Products in Payments
- QELBREE (Drug) $6,751
- Non-Covered Product (Drug) $2,115
- LATUDA (Drug) $1,663
- Adzenys XR-ODT (Drug) $1,273
- VRAYLAR (Drug) $862.69
- INGREZZA (Drug) $518.36
- VYVANSE (Drug) $463.88
- Qelbree (Drug) $383.94
- AUSTEDO (Drug) $192.17
- MYDAYIS (Drug) $175.35
- ARISTADA (Drug) $142.84
- JORNAY PM (Drug) $121.65
- Hetlioz (Drug) $120.75
- TRINTELLIX (Drug) $114.03
- SPRAVATO (Drug) $112.45
- REXULTI (Drug) $106.94
- QUILLIVANT XR (Drug) $105.66
- METHYLPHENIDATE 72 (Drug) $92.43
- QUILLICHEW ER (Drug) $89.07
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $72.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in San Diego
Dr. Jonathan Meyer, M.d, M.D
Psychiatry — Payments: $2.0M
Psychiatry $2.0M
Dr. Sanjai Rao, M.d, M.D
Psychiatry — Payments: $633,149
Psychiatry $633,149
Dr. Murray Stein, M.d., M.p.h, M.D., M.P.H
Psychiatry — Payments: $115,110
Psychiatry $115,110
Dr. Mukesh Sanghadia, M.d., Mrcpsych(Uk), M.D., MRCPSYCH(UK)
Psychiatry — Payments: $82,626
Psychiatry $82,626
Dr. Neil Richtand, M.d, M.D
Psychiatry — Payments: $76,458
Psychiatry $76,458
Clark Smith, Md, MD
Psychiatry — Payments: $72,261
Psychiatry $72,261